Several hematological malignancies are driven by or associated with MYC dysregulation (Delgado and León, 2010), including neoplasms of B-cells, T-cells, plasma cells, and myeloid lineages (Delgado and León, 2010). The gene discussed is MYC; the disease is neoplasm.